About 176,063 results

ALLMedicine™ Type 2 Diabetes Center

Research & Reviews  52,879 results

Polyunsaturated fatty acids and metabolic health: novel insights.
Current Opinion in Clinical Nutrition and Metabolic Care; Djuricic I, Calder PC

Aug 10th, 2022 - This review aims to discuss the potential roles of omega-3 (ω-3) and omega-6 (ω-6) polyunsaturated fatty acids (PUFAs) in the prevention and treatment of metabolic diseases, to provide the latest evidence from epidemiological and clinical studies,...

A review of decision aids to assess cardiovascular risk.
Current Opinion in Endocrinology, Diabetes, and Obesity; Westman EC

Aug 10th, 2022 - Cardiovascular disease remains one of the leading causes of morbidity and mortality today. The major risk factors for cardiovascular disease include type 2 diabetes mellitus, hypertension, tobacco smoking, elevated body mass index, and hyperlipide...

Predictors of HbA1c reduction and hypoglycemia in type 2 diabetes mellitus individuals ...
Current Medical Research and Opinion; Yang W, Du J et. al.

Aug 10th, 2022 - To identify population with type 2 diabetes mellitus (T2DM) who are more likely to benefit from switching to basal insulin (BI) treatment from premixed insulin. This secondary analysis included data from a previously published study (Optimization:...

Masked hypertension in type 2 diabetes: never take normotension for granted and always ...
Blood Pressure; Narkiewicz K, Kjeldsen SE et. al.

Aug 10th, 2022 - Masked hypertension in type 2 diabetes: never take normotension for granted and always assess out-of-office blood pressure.|2022|Narkiewicz K,Kjeldsen SE,Egan BM,Kreutz R,Burnier M,|

MAPKs/AP-1, not NF-κB, is responsible for MCP-1 production in TNF-α-activated adipocytes.
Adipocyte Zhang X, Liu Z et. al.

Aug 10th, 2022 - Obesity is associated with the infiltration of monocytes/macrophages into adipose tissue in which MCP-1 plays a crucial role. But the regulatory mechanism of MCP-1 expression in adipocytes is not well defined. Our results demonstrated that TNF-α i...

see more →

Guidelines  60 results

AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Dise...
Gastroenterology Long MT, Noureddin M et. al.

Jul 17th, 2022 - Nonalcoholic fatty liver disease (NAFLD) is well recognized as a leading etiology for chronic liver disease, affecting >25% of the US and global populations. Up to 1 in 4 individuals with NAFLD have nonalcoholic steatohepatitis, which is associate...

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diag...
Endocrine Practice : Official Journal of the American Col... Cusi K, Isaacs S et. al.

May 16th, 2022 - To provide evidence-based recommendations regarding the diagnosis and management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) to endocrinologists, primary care clinicians, health care professionals, and other...

Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae
Cell Su Y, .

Jan 24th, 2022 - Post-acute sequelae of COVID-19 (PASC) represent an emerging global crisis. However, quantifiable risk-factors for PASC and their biological associations are poorly resolved. We executed a deep multi-omic, longitudinal investigation of 309 COVID-1...

Exercise/Physical Activity in Individuals with Type 2 Diabetes: A Consensus Statement f...
Medicine and Science in Sports and Exercise; Kanaley JA, Colberg SR et. al.

Jan 15th, 2022 - This consensus statement is an update of the 2010 American College of Sports Medicine position stand on exercise and type 2 diabetes. Since then, a substantial amount of research on select topics in exercise in individuals of various ages with typ...

Management of hypertension and renin-angiotensin-aldosterone system blockade in adults ...
BMC Nephrology; Banerjee D, Winocour P et. al.

Jan 5th, 2022 - People with type 1 and type 2 diabetes are at risk of developing progressive chronic kidney disease (CKD) and end-stage kidney failure. Hypertension is a major, reversible risk factor in people with diabetes for development of albuminuria, impaire...

see more →

Drugs  1,560 results see all →

Clinicaltrials.gov  7,921 results

The TRIABETES - ARMMS-T2D Study: A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes

Aug 5th, 2022 - The Specific Aims of the first phase of the study are as follows: Aim 1. To determine the feasibility of performing a randomized trial comparing two major types of bariatric surgery, Laparoscopic Roux en Y Gastric Bypass (RNY) and Laparoscopic Adj...

Early Tracking of Childhood Health Determinants (ETCHED) Study

Aug 5th, 2022 - Approximately 50% of Pima Indian children from diabetic pregnancies develop T2DM by age 25. Since intrauterine exposure to diabetes leads to a higher risk of diabetes in the offspring, the risk might be greatly diminished by preventing diabetes du...

Efficacy and Safety of Berlim 25/10 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia

Aug 5th, 2022 - The purpose of this study is to evaluate the efficacy and safety of Berlim 25/10 association in the treatment of type 2 diabetes mellitus and dyslipidemia.

Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus

Aug 5th, 2022 - The purpose of this study is to evaluate the efficacy and safety of Madalena association in the treatment of type 2 diabetes mellitus.

Investigation the Safety and Efficacy of The Antileukotriene Agents, Montelukast, as Adjuvant Therapy in Obese Patients With Type 2 Diabetes Mellitus

Aug 5th, 2022 - Growing evidences have pointed to the role of 5-lipooxygenase / leukotriene pathway in the pathogenesis of diabesity. Cysteinyl leukotrienes (Cys-LT) are potent inflammatory lipid mediators derived from the 5-lipoxygenase pathway of arachidonic ac...

see more →

News  7,951 results

Atherosclerosis and Diabetes Synergistic, Deadlier in South Asians

Aug 11th, 2022 - The study covered in this summary was published in Preprints for Research Square as a preprint and has not yet been peer reviewed. Key Takeaways South Asians dying with atherosclerosis in the United States were twice as likely to have concurrent d...

Targeting Insulin Resistance Instead of Hyperglycemia in Type 2 Diabetes

Aug 9th, 2022 - Strasbourg, France — An international team coordinated by researcher Vincent Marion, PhD, deputy director of the French National Institute of Health and Medical Research (Inserm)/University of Strasbourg Medical Genetics Laboratory, has published ...

Obesity Drug Shortage Triggers Frustrations, Workarounds

Aug 8th, 2022 - The glucagon-like peptide-1 (GLP-1) agonist semaglutide formulated for treating obesity (Wegovy) had a roaring takeoff a little more than a year ago, with surging patient demand after the US Food and Drug Administration (FDA) approved it in June 2...

Euthyroid Sick Syndrome Hits Many With Diabetic Ketosis 

Aug 5th, 2022 - Researchers published the study covered in this summary on Research Square as a preprint that has not yet been peer reviewed. Key Takeaways The results showed a 58% prevalence of euthyroid sick syndrome (ESS) in 396 adults hospitalized with diabet...

Intrinsic Capacity, Obesity Predict Kidney Disease in T2D

Aug 4th, 2022 - Researchers published the study covered in this summary on Research Square as a preprint that has not yet been peer reviewed. Key Takeaways Older patients (65 years and older) with type 2 diabetes and decreased intrinsic capacity (a measure of phy...

see more →

Patient Education  54 results see all →